For research use only. Not for therapeutic Use.
Olanzapine-d3 is a deuterated form of the antipsychotic drug Olanzapine, featuring three deuterium atoms. This compound is crucial for pharmacokinetic studies, enabling precise LC-MS/MS analysis in drug metabolism and bioavailability research. Olanzapine-d3 serves as an internal standard, offering enhanced accuracy and reliability in quantifying Olanzapine levels in biological samples. Its stable isotope labeling ensures consistency across experiments, supporting advanced research in schizophrenia, bipolar disorder, and other psychiatric conditions. With high purity and stability, Olanzapine-d3 is an essential tool for drug development, therapeutic monitoring, and forensic analysis.
Catalog Number | R004512 |
CAS Number | 786686-79-1 |
Synonyms | 2-Methyl-4-(4-methyl-d3-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Integrol-d3; LY 170053-d3; Lanzac-d3; Oleanz-d3; Oliza-d3; Oltal-d3; Zyprexa-d3; |
Molecular Formula | C17H20N4S |
Purity | ≥95% |
Target | Neuronal Signaling |
Storage | -20°C |
IUPAC Name | 2-methyl-4-[4-(trideuteriomethyl)piperazin-1-yl]-5H-thieno[3,2-c][1,5]benzodiazepine |
InChI | InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,18H,7-10H2,1-2H3/i2D3 |
InChIKey | WXPNDRBBWZMPQG-BMSJAHLVSA-N |
SMILES | [2H]C([2H])([2H])N1CCN(CC1)C2=NC3=CC=CC=C3NC4=C2C=C(S4)C |